U.S. · HEALTH · NOV 10, 9:38 AM ET
STAT+: GLP-1s are given an FDA warning for rare eye condition risk
Reported by 2 outlets in the past day, including STAT, TribLIVE.
1What happened
The FDA warned that GLP-1 drugs carry a potential risk of a rare but serious eye condition sometimes referred to as an “eye stroke.” STAT ↗
2Also reported
The FDA approved a novel drug to reduce recurrence of stroke, the agency is warning that GLP-1s carry a potential risk for an eye condition, and more pharma news of… STAT ↗
Sources
- STAT+: GLP-1s are given an FDA warning for rare eye condition risk ↗STAT
- STAT+: Pharmalittle: We’re reading about an approval for novel drug for strokes, a warning for GLP-1 drugs, and more ↗STAT
- STAT+: FDA warns GLP-1 drugs carry potential risk of rare eye condition ↗STAT
- FDA warns GLP-1 drugs carry potential risk of rare eye condition ↗STAT
- FDA adds rare vision-loss warning to popular GLP-1 drugs ↗TribLIVE